To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our Clinical Trials Program.
If you've been diagnosed with a tumor of the brain or spinal cord, it’s important to be evaluated by neuro-oncology experts before beginning treatment. We can help.
Our Neuro-Oncology Multidisciplinary Team includes neurosurgeons, neurologists, radiation oncologists, otolaryngologists, radiologists, pathologists, pharmacists, nurse practitioners, dietitians, social workers and genetic counselors. The team is entirely focused on treating tumors of the brain and spinal cord and shares its collective expertise to create a customized treatment plan for each patient.
Each patient receives personal attention from the Neuro-Oncology Multidisciplinary Team. During your initial visit, a physician will review your medical records and medical history, x-rays and pathology slides. The team meets regularly to discuss patient care issues and refine individual patient treatment plans.
The team uses the most advanced treatments to achieve optimum success for our patients including:
Here’s what patients can expect from our Neuro-Oncology Multidisciplinary Team:
Originally posted on KevinMD.com Why does one person respond favorably to lung cancer treatment while another does not? The answer lies in the DNA...
910 AM Superstation Urologic oncologist and member of the Genitourinary Oncology Multidisciplinary Team , Isaac Powell, M.D. , joined Angela T. Mo...
Among the Native population, colorectal cancer is the second most common cancer and is the second leading cause of death among men and women, acco...